Therapie der Harninkontinenz

• Literatur

• 1 Abrams P, Andersson KE, Brubaker L. et al. 3rd International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence 2005. Im Internet: http://www.ics.org/Publications/ICI_3/v2.pdf/summary.pdf
• 2 Ascherman JA, Knowles SL, Attkiss K. Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations. Ann Plast Surg 2000; 45: 438-441
• 3 Berghammer P, Pöhnl R, Baur M, Dittrich C. Docetaxel extravasation. Support Care Cancer 2001; 9: 131-134
• 4 Bertelli G, Dini D, Forno GB. et al. Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol 1994; 120: 505-506
• 5 Bertelli G, Gozza A, Forno GB. et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995; 13: 2851-2855
• 6 Dellas C. Crashkurs Pharmakologie. 3. Aufl.. München: Elsevier; 2011
• 7 Füllhase C, Chapple C, Cornu JN. et al. Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol 2013; 64: 228-243
• 8 Gilbar PJ, Carrington CV. The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags. J Oncol Pharm Pract 2006; 12: 113-118
• 9 Grabe M, Bartoletti R, Bjerklund-Johansen TE. European Association of Urology 2014. Guidelines on Urological Infections. Im Internet: https://uroweb.org/wp-content/uploads/19-Urological-infections_LR.pdf
• 10 Gravas S, Bachmann A, Descazeaud A. et al. Members of the European Association of Urology (EAU) Guidelines Office. Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). In: EAU Guidelines 2014 Im Internet: http://www.uroweb.org/guidelines/online-guidelines
• 11 Herlemann A, Gratzke C, Andersson KE. et al. Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors. Urologe 2013; 52: 204-211
• 12 Jordan K, Grothe W, Schmoll HJ. Extravasation zytotoxischer Substanzen: Prävention und Therapie. Dtsch Med Wochenschr 2005; 130: 33-37
• 13 Langer SW. Dexrazoxane for anthracycline extravasation. Expert Rev Anticancer Ther 2007; 7: 1081-1088
• 14 Leyh H, Necknig U. Benignes Prostatasyndrom. In: Schmelz HU, Sparwasser C, Weidner W. (Hrsg.) Facharztwissen Urologie. 2. Aufl.. Heidelberg: Springer; 2010: 593-602
• 15 Luca MG, Bedretdinova D, Bosch LHR. et al. Members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Urinary Incontinence, In: EAU Guidelines 2014. Im Internet: http://www.uroweb.org/guidelines/online-guidelines
• 16 Luke E. Mitoxantrone-induced extravasation. Oncol Nurs Forum 2005; 32: 27-29
• 17 Mouridsen HT, Langer SW, Buter J. et al. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol 2007; 18: 546-550
• 18 Nogler-Semenitz E, Mader I, Fürst-Weger P. et al. Extravasation zytotoxischer Substanzen. Wien Klin Wochenschr 2004; 116: 289-295
• 19 S3-Leitlinie Harnwegsinfektionen. AWMF-Register-Nr. 043/044.
• 20 Sauerland C, Engelking C, Wickham R, Corbi D. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 2006; 33: 1134-1141
• 21 Seitz M, Herlemann A, Magistro G, Stief CG. Diagnostics of benign prostate syndrome. Urologe 2013; 52: 193-196
• 22 Strittmacher F, Madersbacher S, Stief CG. et al. Importance of adrenoceptor blockers and alpha reductase inhibitors. Monotherapy for treatment of benign prostate syndrome. Urologe 2013; 52: 197-203
• 23 Wickham R, Engelking C, Sauerland C, Corbi D. Vesicant extravasation part II: Evidence-based management and continuing controversies. Oncol Nurs Forum 2006; 33: 1143-1150
• 24 Wefer B, Loch A. Harninkontinenz im Erwachsenenalter. In: Schmelz HU, Sparwasser C, Weidner W. Facharztwissen Urologie. 2. Aufl.. Heidelberg: Springer; 2010: 669-696